Related Experiment Video
Updated: Dec 29, 2025
11:35
Selection-dependent and Independent Generation of CRISPR/Cas9-mediated Gene Knockouts in Mammalian Cells
Published on: June 16, 2017
13.1K
Quality Control Strategy for CRISPR-Cas9-Based Gene Editing Complicated by a Pseudogene
Zoé Hanss1, Ibrahim Boussaad1, Javier Jarazo2
1Clinical and Experimental Neuroscience, Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Belvaux, Luxembourg.
Frontiers in Genetics
|January 31, 2020
Summary
This study developed a CRISPR-Cas9 gene editing method to specifically target the GBA gene, crucial for Parkinson's disease research, even with similar pseudogenes present. This technique enables precise genetic modification for studying GBA-related disorders.
Area of Science:
- Biotechnology
- Genetics
- Neuroscience
Background:
- CRISPR-Cas9 gene editing in induced pluripotent stem cells is vital for studying genetic diseases.
- Pseudogenes with high sequence homology can complicate gene editing of target genes.
- The GBA gene is a significant genetic risk factor for Parkinson's disease.
Purpose of the Study:
- To develop a CRISPR-Cas9 strategy for precise gene editing of the GBA gene, avoiding alteration of its pseudogene, GBAP1.
- To demonstrate the correction or insertion of the N370S mutation in GBA.
- To establish a quality control method for identifying correctly edited clones and pseudogene status.
Main Methods:
- Utilized CRISPR-Cas9 technology for targeted gene editing.
- Employed a strategy to differentiate between the GBA gene and its pseudogene, GBAP1.
- Implemented combined fluorescence and PCR-based screening for quality control.
- Performed functional validation to confirm successful gene editing.
Main Results:
- Developed an effective CRISPR-Cas9 gene editing strategy for the GBA gene.
- Successfully edited the N370S mutation in GBA without affecting the GBAP1 pseudogene.
- Established a reliable quality control system for clone screening.
- Confirmed successful gene editing through functional validation.
Conclusions:
- Presents the first CRISPR-Cas9 based editing of a point mutation in the GBA gene.
- Offers a method to overcome challenges posed by pseudogenes in gene editing.
- Facilitates advanced gene engineering for GBA-related research, particularly for Parkinson's disease.
Related Concept Videos
01:28CRISPR/Cas9 Genome Editing
1.5K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
1.5K
01:59CRISPR
57.3K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
57.3K